Background: The aim of this study was to investigate the association between the monocyte-to-high-density lipoprotein-cholesterol ratio(MHR) and the outcomes of patients with coronary artery disease(CAD) who were treated with percutaneous coronary intervention(PCI). Methods: A total of 5679 CAD patients from CORFCHD-PCI, a retrospective cohort study (Identifier: ChiCTR-ORC-16010153), who underwent PCI were included in the study and divided into three tertiles according to their MHR values. The primary outcome was long-term mortality after PCI. The main secondary endpoints were stroke, readmission, and major adverse cardiovascular events(MACEs), defined as the combination of cardiac death, recurrent myocardial infarction, and target vessel reconstruction. The average follow-up time was 35.9±22.6 months. Results: Patients were divided into 3 groups according to MHR tertiles: the 1st tertile (MHR0.61;n=1870). The all-cause mortality(ACM) incidence was significantly lower in the 1st and 2nd tertiles than in the 3rd tertile(adjusted HR=0.658, [95%CI:0.408–0.903],P=0.009 and HR=0.712, [95%CI: 0.538–0.941], P=0.017, respectively). Cardiac mortality(CM) occurred in 235 patients: 60(3.1%) in the 1st tertile group, 74(3.9%) in the 2nd tertile group and 101(5.4%) in the 3rd tertile group. There was a significant difference in the CM incidence between the 1st tertile group and the 3rd tertile group(HR=0.581, [95% CI: 0.406–0.832], P=0.003), and there was also a difference in the CM incidence between the 2nd tertile group and the 3rd tertile group (HR = 0.690, [95%CI:0.506–0.940], P=0.019). Conclusion: The present study indicated that an increased MHR was independently associated with long-term mortality in CAD patients who have undergone PCI.
Background. Coronary heart disease (CHD) is caused by the blockage or spasm of coronary arteries. Evidence shows that liver disease is related to CHD. However, the correlation between the Model for End-Stage Liver Disease (MELD) score and outcomes in patients after percutaneous coronary intervention (PCI) was unclear. Method. A retrospective cohort study involved 5373 patients with coronary heart disease after PCI was conducted from January 2008 to December 2016. Participants were classified to four groups according to the MELD score by quartiles. The primary endpoint was long-term mortality including all-case mortality (ACM) and cardiac mortality (CM). Secondary endpoints included bleeding events, readmission, major adverse cardiovascular events (MACE), major adverse cardiovascular, and cerebrovascular events (MACCE). The longest follow-up time was almost 10 years. Results. There were significant differences in the incidences of ACM ( ) and CM ( ) among the four MELD groups, but there was no significant difference in MACEs ( ), MACCEs ( ), readmission ( ), and bleeding events ( ). After adjusting the age, gender, smoking, drinking status, and diabetes by a multivariable Cox regression analysis, MELD remains independently associated with ACM (HR:1.57, 95%CI 1.052–2.354, ) and CM (HR:1.434, 95% CI 1.003–2.050, ). Conclusion. This study indicated that the MELD score had a strong prediction for long-term mortality in CHD patients who underwent PCI.
18 September 2025 in Frontiers in Cell and Developmental Biology
Congenital heart disease (CHD) is the most prevalent birth defect worldwide, arising from disruptions in the tightly regulated processes of cardiac lineage specification and morphogenesis. Traditional models linking genotype to phenotype have been limited by low resolution and insufficient temporal mapping. Recent advances in single-cell RNA sequencing, spatial transcriptomics, and integrative multi-omics have transformed our understanding of CHD by enabling high-resolution analyses of the cellular origins and regulatory landscapes underlying malformations. This review synthesizes current insights into the developmental trajectories of first and second heart field progenitors, cardiac neural crest cells, and emerging progenitor populations. We highlight how combining genome-wide association studies with single-cell and spatial atlases can map non-coding risk variants to precise spatiotemporal cell states. Additionally, cardiac organoid and engineered developmental models provide innovative platforms for validating gene function and modeling lineage-specific defects in human tissues. Together, these technologies are shifting CHD research toward a mechanistic, cell-type–resolved framework, opening new avenues for precision diagnostics, targeted prevention, and regenerative therapies aimed at restoring normal cardiac development.
The optimal cutoff of the waist-to-hip ratio (WHR) among Han adults in Xinjiang, which is located in the center of Asia, is unknown. We aimed to examine the relationship between different WHRs and cardiovascular risk factors among Han adults in Xinjiang, and determine the optimal cutoff of the WHR.
Objective Risk stratification is challenging in patients with acute ST segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI). We investigated the prognostic value of a novel score system combining leucocyte and platelet counts (COL-P) scores for in-hospital and long-term adverse outcomes. Design This was a retrospective cohort study of patients with STEMI. Setting First Affiliated Hospital of Xinjiang Medical University. Participants A total of 854 STEMI patients with primary PCI were included in this study from November 2009 and December 2015. Primary and secondary outcome measures Major adverse cardiovascular events (MACEs). Methodology The patients were divided into three groups according to the COL-P scores (0, 1 and 2). Cox regression analysis was used to investigate the relation between adverse outcomes and the COL-P score in patients with STEMI. Results A total of 44 patients died in hospital, and 99 within 3-year follow-up after discharge. The in-hospital and 3-year mortality and MACEs were higher in patients with higher COL-P score. Multivariable Cox regression indicated COL-P score was independently associated with long-term mortality (COL-P 1 vs COL-P 0: HR 2.07, 95% CI 1.016 to 5.567, p=0.005; COL-P 2 vs COL-P 0: HR 5.02, 95% CI 1.990 to 9.041, p<0.001). Conclusion The COL-P score was a useful risk system for stratifying high-risk patients with STEMI after primary PCI.
Background: Heart failure (HF) in children under five years of age carries a high risk of in-hospital mortality, yet existing pediatric risk assessment tools lack specificity for this population. There is a pressing need for reliable, interpretable prediction models tailored to pediatric HF.Methods: We retrospectively analyzed 630 hospitalized children under five with heart failure from 2013 to 2024. After excluding those with uncorrected congenital heart disease or terminal comorbidities, 67 variables were assessed, and seven key predictors were identified using the Boruta algorithm. Six machine learning models were developed; the Extreme Gradient Boosting (XGB) model was selected and interpreted using SHAP. External validation included 73 additional cases.Results: The XGB model achieved high predictive performance (AUC: 0.916 training, 0.851 internal validation, 0.846 external validation). The top predictors were NT-proBNP, pH, PCT, LDH, WBC, creatinine, and platelet count. SHAP analysis confirmed the clinical relevance of these variables.Conclusion: This study presents a reliable, interpretable machine learning model for predicting in-hospital mortality in young children with heart failure. It holds promise for early risk stratification and timely intervention, potentially improving outcomes in this high-risk population.